T cell responses to Mycobacterium indicus pranii immunotherapy and adjunctive glucocorticoid therapy in tuberculous pericarditis()

BACKGROUND: In the Investigation of the Management of Pericarditis (IMPI) randomized control, 2x2 factorial trial, Mycobacterium indicus pranii (MIP) immunotherapy, adjunctive corticosteroids or MIP combined with corticosteroids was compared to standard tuberculosis (TB) therapy for tuberculous peri...

Descripción completa

Detalles Bibliográficos
Autores principales: Steigler, Pia, Chhiba, Mukesh, Francis, Veronica, Keyser, Alana, Abrahams, Deborah, Hanekom, Willem, Ntsekhe, Mpiko, Scriba, Thomas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Regular paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218164/
https://www.ncbi.nlm.nih.gov/pubmed/35755143
http://dx.doi.org/10.1016/j.jvacx.2022.100177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218164/
https://www.ncbi.nlm.nih.gov/pubmed/35755143
http://dx.doi.org/10.1016/j.jvacx.2022.100177

Ejemplares similares